At5g15620 Antibody

Shipped with Ice Packs
In Stock

Description

Contextual Clarification

The term "At5g15620" follows Arabidopsis thaliana gene nomenclature (where "At" denotes the species, "5g" indicates chromosome 5, and "15620" is the locus identifier). This gene encodes a protein of unknown function, and there is no peer-reviewed evidence in the provided sources describing a commercially available or experimentally validated antibody targeting this protein.

Potential Misinterpretation

A monoclonal antibody named At5 is documented in the literature (Source ). Key details include:

  • Target: Originally developed against chordin, a notochord-specific antigen in sturgeon.

  • Cross-reactivity: Recognizes neural tissue antigens in higher vertebrates, including human dMAG (myelin-associated glycoprotein derivative) and proteoglycans like phosphacan and neurocan.

  • Applications: Used in immunoblotting and immunohistochemistry for neurological studies.

Relevance: While "At5" shares nomenclature similarity with "At5g15620," these are distinct entities.

Antibody Validation Challenges

Several studies emphasize the importance of rigorous antibody validation (Sources , ):

  • Key Issues: Cross-reactivity, batch variability, and unspecific binding (e.g., anti-GR antibody clone 5E4 binding to AMPD2/TRIM28 instead of GR).

  • Validation Methods:

    • Genetic strategies (knockout/knockdown controls).

    • Orthogonal assays (e.g., IP-MS, functional neutralization).

    • Independent antibody comparisons.

Recommended Actions

To investigate "At5g15620 Antibody":

  1. Verify the Target: Confirm the gene/protein’s biological role using Arabidopsis thaliana databases (e.g., TAIR, UniProt).

  2. Commercial Sources: Search antibody vendors (e.g., Sigma-Aldrich, Abcam) using the UniProt ID or gene symbol.

  3. Custom Development: If no antibody exists, consider:

    • Immunogen Design: Peptide sequences from the At5g15620 protein.

    • Host Species: Rabbit or mouse monoclonal platforms.

    • Validation: Follow IWGAV guidelines (Source ).

Data Gaps and Limitations

  • No studies or reagents specific to At5g15620 were identified in the provided materials.

  • Antibodies against plant proteins often require niche suppliers or custom development.

Related Antibody Case Studies

Antibody NameTargetApplicationsKey FindingsSource
Anti-DEFA5 (1A8/4F5)Crohn’s colitisIHC, Western blot, ELISAValidated for specificity in IBD diagnostics
hMab5.17SARS-CoV-2 S2Viral neutralizationCross-reactive with variants
N6HIV CD4bsBroad neutralizationLow autoreactivity, high efficacy

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
At5g15620 antibody; T20K14.230Putative F-box/LRR-repeat protein At5g15620 antibody
Target Names
At5g15620
Uniprot No.

Q&A

Basic Questions

  • What is the purpose of using antibodies in research?

    • Antibodies are used in research to detect, quantify, and study specific proteins or antigens. They are crucial for understanding protein function, localization, and interactions within cells and tissues.

  • How are antibodies validated for research use?

    • Antibodies are validated through various methods, including Western blot, immunofluorescence, and ELISA. These methods ensure specificity and sensitivity to the target antigen.

  • What types of antibodies are commonly used in research?

    • Commonly used antibodies include monoclonal and polyclonal antibodies. Monoclonal antibodies are produced by a single clone of cells and offer high specificity, while polyclonal antibodies are produced by multiple clones and can recognize multiple epitopes.

Advanced Research Questions

  • How do you optimize antibody concentrations for immunofluorescence experiments?

    • Optimization involves titrating the antibody to find the concentration that provides the best signal-to-noise ratio. This is typically done by testing a range of dilutions (e.g., 1:100 to 1:1000) and selecting the dilution that gives the clearest staining with minimal background.

  • What strategies can be employed to resolve issues with antibody specificity?

    • Strategies include using blocking peptides to confirm specificity, testing antibodies against known positive and negative controls, and using orthogonal methods (like mass spectrometry) to validate protein presence.

  • How can next-generation sequencing (NGS) be applied to antibody research?

    • NGS can be used to analyze antibody sequences, allowing for the identification of novel antibodies, understanding of antibody diversity, and optimization of antibody engineering. Tools like Geneious facilitate the analysis and comparison of large antibody sequence datasets .

  • What role do antibodies play in understanding neuroimmune interactions, such as in conditions like PANS/PANDAS?

    • Antibodies can be used to study autoantibodies that target brain tissues, helping to elucidate the pathogenesis of neuroimmune disorders. For example, antibodies binding to cholinergic interneurons have been implicated in PANS/PANDAS .

  • How can antibodies be used in passive transfer models to study disease mechanisms?

    • Passive transfer models involve transferring antibodies into animals to induce or mimic disease conditions. This approach is used to study the pathogenic effects of antibodies and to test therapeutic interventions, as seen in models like passive transfer myasthenia gravis .

Experimental Design and Data Analysis

  • What considerations should be taken into account when designing experiments involving antibody treatments?

    • Considerations include the selection of appropriate controls, optimization of antibody dosing, and careful monitoring of experimental animals for signs of disease or treatment effects.

  • How can data from antibody experiments be analyzed to address potential contradictions?

    • Data analysis should involve statistical methods to compare treatment groups, and consideration of potential confounding factors. Contradictions can often be resolved by repeating experiments, using orthogonal methods for validation, or re-evaluating experimental design.

Methodological Answers

  • What are the key steps in generating and characterizing monoclonal antibodies for research?

    • Key steps include immunization of animals, fusion of B cells with myeloma cells to create hybridomas, screening for antibody production, cloning of positive hybridomas, and characterization of the antibodies for specificity and affinity.

  • How can researchers ensure reproducibility in antibody-based experiments?

    • Reproducibility can be ensured by using well-characterized and validated antibodies, documenting all experimental conditions, and sharing detailed protocols and data.

Data Tables and Research Findings

While specific data tables for "At5g15620 Antibody" are not available, researchers can apply general principles of antibody research to their studies. For example, when analyzing antibody sequences using NGS, researchers might create tables to compare sequence diversity or clustering patterns among different antibody datasets.

Sequence FeatureDescriptionExample Data
Germline OriginOrigin of antibody sequencesVDJ recombination data
Diversity MetricsMeasures of sequence diversityShannon entropy values
Clustering PatternsGrouping of similar sequencesHeatmap of sequence similarity

These tables would help in understanding the characteristics and potential applications of antibodies in research settings.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.